Işık Atagündüz

6PUBLICATIONS
125CO-AUTHORS
Haematological tumoursHaematologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2026
Intensive Versus Non-Intensive Therapy in Older Patients with Acute Myeloid Leukemia: A Real-World Experience.

|Sep 01, 2026
RNA sequencing detects more challenging cases of somatic hypermutation in the IgHV gene in patients with chronic lymphocytic leukemia.

|Aug 27, 2026
Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

|Jun 27, 2020
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.

Mehmet Soy, Pamir Atagündüz, Işık Atagündüz

|Jun 01, 2020
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.

Mehmet Soy, Gökhan Keser, Pamir Atagündüz

|Jul 23, 2019
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran

Pageof 1

Frequent Collaborators

4 joint publications

Tayfur Toptas

3 joint publications

Tülin Tuğlular Fıratlı

2 joint publications

Arda Bayar

2 joint publications

Gülsan Türköz Sucak